REFERENCES

Agami, R., Blandino, G., Oren, M., and Shaul, Y.(1999). Interaction of c-Abl and p73alpha and their collaboration to induce apoptosis. Nature 399:809-813.

Alexandropoulos, K., Cheng, G., and Baltimore, D.(1995). Proline-Rich Sequences that Bind to Src Homology 3 Domains with Individual Specificities. Proc Nat/ Acad Sci US A 92: 3110-3114.

Alnemri, E. S., Fernandes-Ainemri, T., and Litwack, G.(1995). Cloning and expression of four novel isoforms of human interleukin-1 beta converting enzyme with different apoptotic activities. J Bioi Chern 270:4312-4317.

Arrowsmith, C. H.(1999). Structure and function in p53 family. Cell Death Differ6:1169-1173.

Atadja, P., Wong, H., Garkavtsev, 1., Veillette, C., and Riabowol, K.(1995). Increased activity of p53 in senescing fibroblasts. Proc Nat/ Acad Sci U SA 92:8348-8352.

Aurelio, O.N., Kong, X.T., Gupta, S., and Stanbridge, E.J.(2000). p53 mutants have selective dominant-negative effects on apoptosis but n.ot growth arrest in human cancer cell lines. Mol Cell Bioi 20:770-778.

Auricchio, F., Migliaccio, A., Castoria, G., Lastoria, S., and Rotondi, A.(1982). Evidence that in vivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm. Biochem Biophys Res Commun 106:149-157.

Avantaggiati, M.L., Ogryzko, V., Gardner, K., Giordano, A.A., Levine, A.S., and Kelly, K.(1997). Recruitment of p300/CBP in p53-dependent signal pathways. Cell89, 1175-1184.

Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., White, R., and Vogelstein, B.(1989). Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.Science 244:217-221.

Baker, S.J., Markowitz, S., Fearon, E. R., Wilson, J. K., and Vogelstein, B.(1990). Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915.

Balint, E., Bates, S., and Vousden, K. H.(1999) MDM2 binds p73 alpha without targeting degradation. Oncogene 18:3923-3929.

Bannister, A. J., and Kouzarides, T.(1996). The CBP co-activator is a histone acetyl transferase. Nature 384, 641-643.

Barford, D. (1999). Colworth Medal Lecture. Structural studies of reversible protein phosphorylation and protein phosphatases. Biochem Soc Trans 27:751-766.

Barford, D.(1996). Molecular mechanism of the protein serine/threonine phosphatases. Trends Biochem Sci 21 :407-412.

' Bargonetti, J., Reynisdittir, 1., Friedman, P.N., and Prives, C.(1992). Site-specific binding to wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. Genes Dev 10, 1886-1898.

Baskaran R., Wood, L. D., Whitaker, L. L., Canman, C.E., Morgan, S. E., Xu, Y., Barlow, C., Baltimore, D., Wynshaw-Boris, A., Katan, M.B., and Wang, J. Y.(1997). Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiaton. Nature 387, 516-519.

Bennett, M., Macdonald, K., Shiu-Wan, C., Luzio, J. P., Simari, R., and Weissberg, P.(1998). Cell Surface Trafficking of Fas: A Rapid Mechanism of p53-Mediated Apoptosis. Science 282: 290-293.

87

Beroud, C., and Soussi, T.(1998). p53 gene mutation: software and database. Nucleic Acids Res 26:200-204.

Bliska, J. B., Guan, K. L., Dixon, J. E., and Falkow, S.(1991 ). Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Nat/ Acad Sci USA 88:1187-1191.

Blomberg, 1., and Hoffmann, 1.(1999). Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases. Mol Cell Bioi 19:6183-6194.

Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B., and Mandel, J.L.(2000). Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.Hum Mol Genet 9:2223-2229.

Bond, J., Haughton, M., Blaydes, J., Gire, V., Wynford-Thomas, D., and Wyllie, F.(1996) Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene 13, 2097-2104.

Boudreau, N., Sympson, C. J., Werb, Z., and Bissell, M. J.(1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.

Brewer, C. B.(1994). Methods in Cell biology; Protein expression in Animal cells (Roth, M.G., ed) 43: 233-245, Academic presslnc., New York.

Buckbinder, L., Talbott, R., Velascomiguel, S., Takenaka, 1., Faha, B., Seizinger, B.R., and Kley, N.(1995) Induction ofthe growth inhibitor IGF-binding protein-3 by p53. Nature 377, 646-649.

Caelles, C., Heimberg, A., and Karin, M.(1994) p53-dependent apoptosis in the absence of p53-target genes. Nature 370, 220-223.

Calkhoven, C. F., and Geert, A. B.(1996). Multiple steps in the regulation of transcription-factor level and activity. Biochem J 317:329-342.

Camps, M., Nichols, A., and Arkinstall, S.(1993) Dual-specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14:6-16.

Cane, D.P., and Crawford, L.V.(1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 76:2420-2424.

Canman, C. E., Lim, D. S., Cimprich, K. A., Taya, Y., Tarnai, K., Sakaguchi, K., Appella, E., Kastan, M. B., and Siliciano, J. D.(1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281:1677-1679.

Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T.A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L.A., Huebner, K., and Black, R. A.(1992). Molecular cloning of the interleukin-1 beta converting enzyme. Science 256:97-100.

Cerretti.,D. P., Hollingsworth, L. T., Kozlosky, C. J., Valentine, M. B., Shapiro, D. N., Morris, S. W., and Nelson, N.(1994). Molecular characterization of the gene for human interleukin-1 beta converting enzyme (IL 1 BC). Genomics 20:468-473.

Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., and Vogelstein, B.(1999). 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401:616-620.

Charbonneau, H., Tonks, N. K., Kumar, S., Diltz, C. D., Harrylock, M., Cool, D. E., Krebs, E. G., Fisher, E. H., and Walsh, K. A.(1989). Human placenta protein tyrosine phosphatase: aminoacid

88

sequence and relationship to a family of receptor-like proteins. Proc Nat/ Acad Sci USA 86: 5252-5256.

Chen, P. L., Chen, Y. M., Bookstein, R., and Lee, W. H.(1990). Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576-1580.

Chen, X., Zheng, Y., Zhu, J., Jiang, J., and Wang, J.(2001). p73 is transcriptionally regulated by DNA damage, p53, and p73. Oncogene 20: 769-774.

Chin, Y. E., Kitagawa, M., Kuida, K., Flavell, R. A., and Fu, X. Y.(1997). Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Bioi 17: 5328-5337.

Chowdary D. R., Dermody, J.J., Jha, K.K., and Ozer, H.L..(1994). Accumulation of p53 in a mutant cell line defective in the ubiquitin pathway. Mol Cell Bio/14, 1997-2003.

Cohen, G.M.(1997). Caspases: the executioners of apoptosis. Biochem J 326 (Pt 1 ):1-16.

Collins, M. K., Perkins, G. R., Rodriguez-Tarduchy, G., Nieto, M. A., and Lopez-Rivas, A.(1994) Growth factors as survival factors: regulation of apoptosis. Bioessays 16:133-138.

Cool, D. E., Tonks, N. K., Charbonneau, H., Walsh, K. A., Fisher, E. H., and Krebs, E. G. (1989). eDNA isolated from a human T-cell library encodes a member of the protein tyrosine phosphatase family. Proc Nat/ A cad Sci USA 86 : 525 7-5261.

Crook, T., Marston, N.J., Sara, E.A., and Vousden, K.H.(1994). Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell79, 817-827.

Cross, S.M., Sanchez, C. A., Morgan, C.A., Schimke, M.K., Ramel, S., ldzerda, R. L., Raskind, W.H., and Reid, B.J (1995). A p53-dependent mouse spindle checkpoint. Science 267, 1582-1584.

Cryns, V., and Yuan, J.(1998). Proteases to die for. Genes Dev 12:1551-1570.

Dameron, K. M., Volpert, 0. V., Tainsky, M. a., and Bouck, N.(1994). Control of angiogenesis in fibroblasts by p53 regulation of angiogenesis of thrombospondin-1. Science 265, 1582-1584.

Darnell, J. E. Jr.(1997). STATs and gene regulation. Science 277:1630-1635.

Day, C. L., Dupont, C., Lackmann, M., Vaux, D. L., and Hinds, M. G.(1999). Solution structure and mutagenesis of the caspase recruitment domain (CARD) from Apaf-1.Cell Death Differ 6:1125-1132.

De Cesare, D., Fimia, G. M., and Sassone-Corsi, P.(1999). Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem Sci 24:281-285.

De Laurenzi, V. D., Costanzo, A., Barcaroli, D., Terrinoni, A., Falco, M., Annicchiarico-Petruzzelli, M., Levrero, M., and Melina, G. (1998). Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med 188: 1763-1768.

De Laurenzi, V. D., Catani, M. V., Terrinoni, A., Corazzari, M., Melina, G., Costanzo, A., Levrero, M., and Knight, R.A.(1999). Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta.Cell Death Differ 6:389-390.

De Laurenzi,V. D., Raschella, G., Barcaroli, D., Annicchiarico-Petruzzelli, M., Ranalli, M., Catani, M. V., Tanno, 8., Costanzo, A., Levrero, M., and Melina, G.(2000). Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Bioi Chern 275:15226-15231.

89

Deleo, A. B., Jay, G., Appella, E., Dubois, G. C., Law, L. W., and Old, L. J.(1979). Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Nat/ Acad Sci U SA 76:2420-2424.

Derijard, B., Hibi, M., Wu, I. H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R.J.(1994). JNK1: a Protein Kinase Stimulated by UV Light and Ha-Ras That Binds and Phosphorylates the c-Jun Activation Domain. Cell 76: 1025-1037.

Detjen, K.M., Farwig, K., Welzel, M., Wiedenmann, B., and Rosewicz, S.(2001). Interferon y inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49:251-262.

Diamond, R. H., Cressman, D. E., Laz, T. M., Abrams, C. S., and Taub, R.(1994). PRL-1, a unique nuclear protein tyrosine phosphatase, affects cell growth. Mol Cell Bio/14:3752-3762.

Di Como, C. J., Gaiddon, C., and Prives, C.(1999). p73 function is inhibited by tumor-derived p53 mutants in mammalian cells. Mol Cell Bio/19~ 1438-1449.

Di Cristofano, A, and Pandolfi, P. P.(2000) The multiple roles of PTEN in tumor suppression.Cell 100:387-390.

Di Giovine FS, and Duff, G. W.(1990). lnterleukin 1: the first interleukin. lmmunol Today 11:13-20.

Dinarello CA. (1991). lnterleukin-1 and interleukin-1 antagonism. B/ood77:1627-1652.

Ding, Y., Inoue, T., Kamiyama, J., Tamura, Y., Ohtani-Fujita, N., lgata, E., and Sakai, T. (1999). Molecular cloning and functional characterization of the upstream promoter region of the human p73 gene. DNA Res 6: 347-351.

Dobbelstein, M., and Roth, J.(1998). The large T antigen of simian virus 40 binds and inactivates p53 but not p73. J Gen Virol 79 ( Pt 12):3079-3083. ·

Donehower, L.A., Godley, L. A, Aldaz, C. M., Pyle, R., Shi, Y. P., Pinkel, D., Gray, J., Bradley, A, Medina, D., and Varmus,H. E.(1995). Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9:882-895.

Donehower, L. A, Harvey, M., Slagle, B.L., McArther, M.J., Montgomery, Jr. C.A., Butel, J.S., and Bradley, A..(1992). Mice deficient for p53 are developmently normal but susceptible to spontaneous tumors. Nature 356,215-221.

Dosil, M., Leibman, N., and Lemischka, I. R.(1996). Cloning and characterization of fetal liver phosphatase 1, a nuclear protein tyrosine phosphatase isolated from hematopoietic stem cells. Blood 88:4510-4525.

Draetta, G., and Eckstein, J. (1997). Cdc25 protein tyrosine phosphatases in cell proliferation. Biochim Biophys Acta 1332: M53-M63.

Elchebly, M., Payette. P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., Normandin, D., Cheng, A., Himms-Hagen, J., Chan., C. C., Ramachandran, C., Gresser, M. J., Tremblay, M. L., and Kennedy., B. P.(1999). Increased insulin sensitivity and obesity resistance in mice lacking theprotein tyrosine phosphatase-1 B gene. Science 283:1544-1548.

EI-Deiry, W. S., Kern, S.E., Pientenpol, J.A., Kinzler, K.W., and Vogelstein, B. (1992) Definition of a consensus binding site for p53. Nat Genet 1, 45-49.

EI-Deiry, W. 8.(1998). Regulation of p53 downstream genes. Seminars in Cancer Bio/8, 345-57.

90

Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, 0., and Oren, M.(1989). Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Nat/ A cad Sci US A 86:8763-8767.

Evans, J. L., and Jallal, B.(1999). Protein tyrosine phosphatases : their roles in insulin action and potential as drug targets. Exp Opin Invest Drugs 8:139-160.

Fantuzzi,G., Puren, A. J., Harding, M. W., Livingston, D. J., and Dinarello, C. A.(1998). lnterleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta­converting enzyme (caspase-1)-deficient mice. B/ood91:2118-2125.

Fillipovich, 1., Sorokina, N., Gatei, M., Haupt, Y., Hobson, K., Moallem, E., Spring, K., Mould, M., McGuckin, M.A., Lavin, M.F., and Khanna, K. K.(2001). Transactivation-deficient p73 a. (p73 pexon2) inhibits apoptosis and competes with p53. Oncogene 20: 514-522.

Fisher, D. E.(1994). Apoptosis In Cancer Therapy: Crossing the Threshold.Cell78: 539-542.

Gaddon, C., Lokshin, M., Ahn, J., Zhang, T., ans Prives, C.(2001). A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain. Mol Cell Bio/21: 187 4-1887.

Galaktionov, K., and Beach, D.(1991). Specific activation of Cdc25 tyrosine phosphatases by B-type cyclins. Cell67:1181-1194.

Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., and Beach D.(1995). CDC25 phosphatases as potential human oncogenes. Science 269:1575-1577.

Ganapati, U., Gupta, S., Radha, V., Sudhakar, C., Manogaran, P. S., and Swarup, G.(2001). A nuclear protein tyrosine phosphatase induces shortening of G1 phase and increase in c-Myc protein level. Exp Cell Res 265:1-10.

Ganesh, S., Agarwala, K. L., Ueda, K., Akagi, T., Shoda, K., Usui, T., Hashikawa, T., Osada, H., Delgado-Escueta, A. V., and Yamakawa, K.(2000). Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum Mol Genet 9:2251-2261.

Gaozza, E., Baker, S. J., Vora, R. K., and Reddy, E.P.(1997). AATYK: a novel tyrosine kinase induced during growth arrest and apoptosis of myeloid cells. Oncogene 15:3127-3135.

Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A, Quintal, L., Sekut, L., Talanian, R., Paskind, M., Wong, W., Kamen, R., Tracey, D., and Allen, H.(1997). Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386:619-623.

Ghosh, S., May, M. J., and Kopp, E. 8.(1998). NF-kappa Band Rei proteins: evolutionarily conserved mediators of immune responses. Annu Rev /mmuno/16:225-260.

Goldstein, B. J., Li, P.M., Ding, W., Ahmad, F., and Zhang, W. R.(1998). Regulation of insulin action by protein tyrosine phosphatases. Vitam Harm 54: 67-96.

Gong, J. G., Costanzo, A., Yang, H. Q., Melina, G., Kaelin, W. G. Jr., Levrero, M., and Wang, J. Y.(1999). The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399:806-809.

Gould, K. L., Moreno, S., Tonks, N. K., and Nurse, P.(1990). Complementation ofthe mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase. Science 250:1573-1576.

91

Graeber, T.G., Peterson, J. F., Tsai, M., Monica, K., Fornace, A. J. Jr., and Giaccia, A. J.(1994).Hypoxia induces accumulation of p53 protein, but activation of a G1- phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Bioi 14: 6264-6277.

Grinstein, A. R., Schwartz, D., and Rotter, V.(1995). Accumulation of wild-type p53 protein upon g­irradiation induces a G2 arrest-dependent immunoglobulin k light chain expression. EMBO J 14: 1392-1401.

Gu, W., and Roeder, R. G.(1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell90,595-606.

Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M.A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., Kurimoto, M., Tanimoto, T., Flavell, R. A., Sato, V., Harding, M. W., Livingston, D. J., and Su, M. S.(1997).Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 275:206-209.

Gupta, S., Radha, V., Furukawa, Y., and Swarup, G.(2001 ). Direct transcriptional activation of human caspase-1 by tumor suppressor p53. J Bioi Chern 276:10585-1 0588.

Hagenbuchle, 0., and Wellauer, P. K.(1992). A rapid method for the isolation of DNA-binding proteins from purified nuclei of tissues and cells in culture. Nucleic Acids Res 20:3555-3559.

· Hainaut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., Harris, C. C., and Montesano, R.(1998). IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res 26:205-213.

Hainaut, P., and Hollstein, M.(2000). p53 and human cancer: the first ten thousand mutations. Adv Cancer Res. 77:81-137.

Halazonetis, T. D. and Kandil, A. N.(1993). Wild-type p53 adopts a "mutant"-like conformation when bound to DNA. EMBOJ 12: 1021-1028.

Harlow, E., Williamson, N. M., Ralston, R., Helfman, D. M., and Adams, T.E.(1985). Molecular cloning and in vitro expression of a eDNA clone for human cellular tumor antigen p53. Mol Cell Bioi 5:1601-10.

Harper, J. W., Elledge, S. J., Keyomarsi, K., Dynlacht, B., Tsai, L-H., Zhang, P., Dobrowolski, S., Bai, C., Cannell-Croley, L., Swindell, E., Fox, M. P., and Wei, N.(1995). Inhibition of cyclin-dependent kinases by p21. Mol Bioi Ce//6: 387-400.

Harvey, M., Sands, A. T., Weiss, R. S., Hegi, M. E., Weiseman, R. W., Pantszis, P., Giovanella, B. C.,Tainsky, M.A., Bradley, A.,and Donehower, L. A .. (1993). In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8, 2457-2467.

Hermeking, H., Lengauer, C., Polyak, K., He, T. C., Zhang, L., Thiagalingam, S., Kinzler, K. W., and Vogelstein, B.(1997). 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Ce//1 :3-11.

Herwig, S., and Strauss, M.(1997). The retiooblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246(3):581-601.

Helin K. (1998).Regulation of cell proliferation by the E2F transcription factors.Curr Opin Genet Dev 8:28-35.

Higashino, F., Pipas, J. M., and Shenk, T.(1998). Adenovirus E4orf6 oncoprotein modulates the function of the p53-related protein, p73. Proc Nat/ Acad Sci USA 95:49-53.

92

. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R.(1989). Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.

Hoffmann, 1., Draetta, G., and Karsenti, E. (1994). Activation of the phosphatase activity of human Cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 13:4302-4310.

Hollstein, M,, Sidransky, D., Vogelstein, B., and Harris, C. C.(1991). p53 mutations in human cancers. Science 253:49-53.

Honda, R., and Yasuda, H.(1999). Association of p19(ARF) with MDM2 inhibits ubiquitin ligase activity of MDM2 for tumor suppressor p53. EMBO J 18:22-27.

Hood, J. K., and Silver, P. A.(1999). In or out? Regulating nuclear transport. Curr Opin Cell Bioi 11:241-247.

Humke, E. W., Shriver, S. K., Starovasnik. M. A., Fairbrother, W. J., and Dixit, V. M.(2000). ICEBERG: a novel inhibitor of interleukin-1beta generation. Cell 103:99-111.

Hunter, T., and Sefton, B. M.(1980). Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Nat/ Acad Sci USA 77: 1311-1315.

Hunter, T. ( 1996). Tyrosine phosphorylation: past, present and future.Biochem Soc Trans 24:307-327.

Hunter, T.(2000). Signaling-2000 and Beyond. Ce//100: 113-127.

Hunter, T., and Karin, M.(1992).The Regulation of Transcription by Phosphorylation Cell 70: 375-387.

Hupp. T. R., and Lane, D.P.(1994). Two distinct signalling pathways activate the latent DNA-binding function of p53 in a casein kinase If-independent manner. J Bioi Chern 270, 18165-18174.

Hupp, T. R., Sparks, A., and D. P. Lane.(1995). Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245.

lbarra-Sanchez, M. J., Wagner, J., Ong, M. T., Lampron, C., and Tremblay, M. L.(2001 ). Murine embryonic fibroblasts lacking TC-PTP display delayed G1 phase through defective NF-kappaB activation. Oncogene 20:4728-3479.

Inoue, H., Nojima, H., and Okayama, H.(1990). High efficiency transformation of Escherichia Coli with plasmids. Gene 96:23-28.

International Human Genome Sequencing Consortium.(2001). Initial sequencing and analysis of the human genome. Nature 409:860-921.

Irwin, M., Marin, M. C., Phillips, A. C., Seelan, R. S., Smith, D. 1., Liu, W., Flores, E. R., Tsai, K. Y., Jacks, T., Vousden, K. H., and Kaelin, W. G. Jr.(2000). Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 407:645-648.

Irwin, M S., and Kaelin, W. G. Jr.(2001). Role of the newer p53 family proteins in malignancy. Apoptosis 6:17-29.

lwase, S., Furukawa, Y., Kikuchi, J., Saito, S., Nakamura, M., Nakayama, R., Horiguchi-Yamada, J., and Yamada, H.(1999). Defective binding of IRFs to the initiator element of interleukin-1 beta­converting enzyme (ICE) promoter in an interferon-resistant Daudi subline. FEBS Lett 450:263-267.

93

Jarry, A., Vallette, G., Cassagnau, E., Moreau, A., Sou-Hanna, C., Lemarre, P., Letessier, E., Le Neel, J. C., Galmiche, J. P., and Laboisse, C. L.(1999). lnterleukin 1 and interleukin 1beta converting enzyme (caspase 1) expression in the human colonic epithelial barrier. Caspase 1 downregulation in colon cancer.Gut 45:246-251.

Jeffrey, P. D., Gorina, S., and Pavletich, N.P.(1995).Crystal structure of the tetramerization domain of p53 tumor suppressor at 1. 7 angstroms. Science 267, 1498-1502.

Jinno, S., Suto, K., Nagata, A., Igarashi, M., Kanaoka, Y., Nojima, H., and Okayama H. (1994). Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J. 3:1549-1556.

Jones, S. N., Roe, A.E., Donehower, L.A., and Bradley, A.: Rescue of embryonic lethality in MDM2-deficient mice by absence of p53. Nature 378, 206-208 (1995)

Jordan, J., Galindo, M. F., Prehn, J. H., Weichselbaum, R. R., Beckett, M., Ghadge, G. D., Roos, R. P., Leiden, J. M., and Miller, R. J.(1997). p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J Neurosci 17:1397-1405. ,

Jost, C. A., Marin, M. C., and Kaelin, W. G. Jr.(1997). p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389:191-194.

Kaelin, W. G. Jr.(1999). The p53 gene family. Oncogene 18:7701-7705.

Kaghad, M., Bonnet, H., Yang,A, Creancier, L., Biscan, J.C., Valent, A., Minty, A., Chalon, P., Lelias, J.M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D.(1997). Monoallelically expressed gene related to p53 at 1 p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819.

Kamatkar, S., Radha, V., Nambirajan, S., Reddy, R. S., and Swarup, G.(1996). Two splice variants of a tyrosine phosphatase differ in substrate specificity, DNA binding, and subcellular location. J Bioi· Chern 271:26755-26761.

Kamijo, T., Weber, J.D., Zambetti, G., Zindy, F., Roussel, M.F., and Sherr, C.J.(1998). Functional and physical interactions of the ARF tumor suppressor with p53 and MDM2. Proc Nat/ Acad Sci USA 95, 8292-8297.

Kaniga, K., Uralil, J., Bliska, J. B., and Galan, J. E.(1996). A secreted protein tyrosine phosphatase with modular effector domains in the bacterial pathogen Salmonella typhimurium. Mol Microbial 21:633-641.

Kannan, K., Amariglio, N., Rechavi, G., Jakob-Hirsch, J., Kela, 1., Kaminski, N., Getz, G., Domany, E., and Givol, D.(2001) DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 20:2225-2234.

Khanna, K. K .. , Keating, K. E., Kozlov, S., Scott, S.,Gatei, M.,Hobson, K., Taya., Y., Gabrielli, B., Chan, D., Lees-Miller, S. P., and Lavin, M. T.(1998). ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 20, 398-400.

Khokhlatchev, A. V., Canagarajah, B., Wilsbacher, J., Robinson, M., Atkinson, M., Goldsmith, E., and Cobb, M.H.(1998). Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93:605-615.

Klingler-Hoffmann, M., Fodero-Tavoletti, M. T., Mishima, K., Narita, Y., Cavenee, W. K., Furnari, F. B., Huang, H. J., and Tiganis, T.(2001). The protein tyrosine phosphatase TCPTP suppresses the tumorigenicity of glioblastoma cells expressing a mutant epidermal growth factor receptor. J Bioi Chem Aug 20 [epub ahead of print]

94

Klaman, L. D., Boss, 0., Peroni, 0. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., Moghal, N., Lubkin, M., Kim, Y. B., Sharpe, A. H., Stricker-Krongrad, A., Shulman, G. 1., Neel, B. G., and Kahn, B. B. (2000).Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1 B-deficient mice. Mol Cell Bio/20:54 79-5489.

Ko, L. J., and Prives, C.(1996). p53: puzzle and paradigm. Genes Dev 10, 1054-1072.

Kortenjann, M., and Shaw, P.E.(1995). The growing family of MAP kinases: regulation and specificity. Grit Rev Oncog 6:99-115.

Kubbutat, M.H., Jones, S.N., and Vousden, K.H.(1997). Regulation of p53 stability by MDM2. Nature. 387:299-303.

Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S., and Flavell, R.A.(1995). Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267:2000-2003.

Laemmli, U.K.(1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.

Lam, M. H., Michell, B. J., Fodero-Tavoletti, M. T., Kemp, B. E., Tonks, N. K., and Tiganis, T.(2001). Cellular stress regulates the nucleocytoplasmic distribution of the protein tyrosine phosphatase TCPTP. J Bioi Chern Jul 30 [epub ahead of printJ

Lammer. C., Wagerer, S., Saffrich, R., Mertens, D., Ansorge, W., and Hoffmann, 1.(1998). The Cdc25B phosphatase is essential for the G2/M phase transition .in human cells. J Cell Sci 111:2445-2453.

Lane, D.P.(1992). Cancer. p53, guardian ofthe genome. Nature 358:15-16.

Latchman, D., (1995) Gene regulation: a eukaryotic perspective (Chapman & Hall London).

Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Bernstein, A.(1989) High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of p53 oncogene. Mol Cell Biol9, 3982-3991.

Lee, C. W., and LaThangue, N. B.(1999). Promoter specificity and stability control of the p53-related protein p73. Oncogene 18:4171-14181.

Lee, E.(1995). Cyclin dependent kinase regulation. Curr opin cell Biol7:773-780.

Lee, S. H., Stehlik, C., and Reed, J. C.(2001).COP, a CARD-containing protein and inhibitor of caspase-1 activation processing. J Bioi Chern Jun 29 [epub ahead of print]

Levrero, M., De Laurenzi, V., Costanzo, A., Gong, J., Wang, J.Y., and Melina, G.(2000). The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci 113:1661-1670.

Levine, A .. J., (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.

Levine, A. J., Momand, J., and Finlay, C.A.(1991). The p53 tumor suppressor gene. Nature 351,453-456.

Levinson, A. D., Oppermann, H., Varmus, H. E., and Bishop, J. M.(1980). The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. J Bioi Chern 255:11973-11980.

95

Li, L., and Dixon, J. E.(2000). Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases. Semin /mmuno/12:75-84.

Li, P., Allen, H., Banerjee, S., Franklin, S., Herzog, L., Johnston, C., McDowell, J., Paskind, M., Rodman, L., Salfeld, J., et ai.(1995).Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Ce//80:401-411.

Li, Q., Karam, S.M., and Gordon, J. 1.(1995).Simian Virus 40 T Antigen-induced Amplification of Pre­parietal Cells in Transgenic Mice. J Bioi Chem 270: 15777-15788.

Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M.(1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827.

Linzer, D. 1., and Levine, A. J.(1979). Characterization of a 54K Dalton Cellular SV40 Tumor Antigen Present In SV40-transformed Cells and Uninfected Embryonal Carcinoma Cells. Cell 17: 43-52.

Lissy, N. A., Davis, P. K., Irwin, M., Kaelin, W. G., and Dowdy. S. F.(2000). A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature 407:642-645.

Liu, K., Lemon, B., and Traktman, P.(1995). The dual-specificity phosphatase encoded by vaccinia virus, VH1, is essential for viral transcription in vivo and in vitro. J Virol 69:7823-7834.

Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D.(1992). Altered Cell Cycle Arrest and Gene Amplification Potential Accompany Loss of Wild-type p53. Cell 70: 923-935.

Lorenzen, J. A., Dadabay, C. Y., and Fischer, E. H.(1995). COOH-terminal sequence motifs target the T cell protein tyrosine phosphatase to the ER and nucleus. J Cell Bioi 131:631-643.

Los, M., Van De Craen, M, Penning, L. C., Schenk, H., Westendrop, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K.(1995). Requirement of an ICE/CED-3 protease for FAS/AP0-1 mediated apoptosis. Nature 375: 81-83.

Los, M., Herr, 1., Friesen, C., Fulda, S., Schulze-Osthoff, K., and Debatin, K. M. (1997). Cross­resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 90:3118-3129.

Los, M., Wesselborg, S., and Schulze-Osthoff, K.(1999). The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10:629-639.

Lu, H., and Levine, A.J.(1995). Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc Nat/ Acad Sci USA 92, 5154-5158.

Maehama, T., and Dixon, J. E.(1998). The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositoi3,4,5-Trisphosphate. J Bioi Chern 273: 13375-13378.

Mai, M., Huang, H., Reed, C., Qian, C., Smith, J. S., Alderete, B., Jenkins, R., Smith, D. 1., and Liu, W.(1998). Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions. Genomics 51:359-363.

Mailand, N., Falck, J., Lukas, C., Syljuasen, R. G., Welcker, M., Bartek, J., and Lukas, J. (2000). Rapid destruction of human Cdc25A in response to DNA damage. Science 288:1425-1429.

Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F. Jr., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A..et al. (1990).Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250:1233-1238.

96

Maniatis, T., Fritsch, E. F., and Sambrook, J.(1982). Molecular cloning : A laboratory manual. Cold Spring Harbour Laboratory, CSH, NY.

Mao, P. L., Jiang, Y., Wee, B. Y., and Porter. A. G.(1998). Activation of Caspase-1 in the Nucleus Requires Nuclear Translocation of Pro-aspase-1 Mediated by Its Prodomain. J Bioi Chem 273: 23621-23624.

Marin, M. C., Jost,C.A., Irwin, M.S., DeCaprio, J.A., Caput, D., and Kaelin, W. G. Jr.(1998). Viral oncoproteins discriminate between p53 and the p53 homolog p73. Mol Cell Bio/18, 6316-6324.

Mayo, L. D., and Donner, D.B.(2001 ). A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of MDM2 from the cytoplasm to the nucleus. Proc Nat/ Acad Sci U SA Aug 14 [epub ahead of.print]

Meek, D. (1994). Post-translational modifications ofp53. Semin CancerBio/5: 203-210.

Miller, F. D., Pozniak, C. D., and Walsh, G. S.(2000). Neuronal life and death: an essential role for the p53 family. Cell Death Differ 7:880-888.

Mills, A. A., Zheng, B., Wang, X. J., Vogel, H., Roop, D. R., and Bradley, A.(1999). p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.

Minassian, et al., 2000; Minassian, B. A., lanzano, L., Meloche, M., Andermann, E., Rouleau, G. A., Delgado-Escueta, A. V., and Scherer, S. W.(2000). Mutation spectrum and predicted function of laforin in Lafora's progressive myoClonus epilepsy. Neurology 55:341-346.

Mitra, S. K., and Swarup, G.(2001). Inhibition of anchorage independent cell growth, adhesion and cyclin D1 gene expression by a dominant negative mutant of a tyrosine phosphatase. Exp Cell Res 269 In press.

Mittnacht, S.(1998). Control of pRB phosphorylation. Curr Opin Genet Dev 8:21-27.

Miura, M., and Yuan, J.(2000). Transient transfection assay of cell death genes.Methods Enzymol 322:480-492.

Miura, M., Zhu, H., Rotella, R., Hartwieg, E. A., and Yuan, J.(1993).1nduction of Apoptosis In Fibroblasts by I L-1 ~converting Enzyme, a Mammalian Homolog of the C. Elegans Cell Death Gerie ced-3. Cell 75: 653-660.

Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B., and Reed, J. C.(1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805.

Molinari, M., Mercurio, C., Dominguez, J. Goubin, F., and Draetta, F.G. (2000). Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Rep 1:71-79.

Moller, N. P. H., Iversen, L., Anderson, H. S., and McCormack, J. G.(2000). Protein tyrosine phosphatases (PTPs) as drug targets : inhibitors of PTP1B for the treatment of diabetes. Curr Opin Drug Discov Dev 3:527-540.

MontesdeOca Luna, R., Wagner, D. S., and Lozano, G.(1995). Rescue of early embryonic lethality in MDM2-deficient mice by deletion of p53. Nature 378, 203-206.

97

Mosinger, B. Jr., Tillmann, U., Westphal, H., and Tremblay, M. L.(1992). Cloning and characterization of a mouse eDNA encoding a cytoplasmic protein-tyrosine-phosphatase. Proc Nat/ Acad Sci U S A 89:499-503 .

Myers, M.P., Pass, 1., Batty, I. H., Vander Kaay, J., Stolarov, J.P., Hemmings, B. A., Wigler, M. H., Downes, C. P., and Tonks, N. K. (1998). The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Nat/ Acad Sci us A 95: 13513-13518.

Nakano, K., and Vousen, K. H.(2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7:683-694.

Nambirajan, S., Reddy, R. S., and Swarup, G. (1995). Enhanced expression of a chromatin associated protein tyrosine phosphatase during Go to S transition. J Biosci 20:461-471.

Nambirajan, S., Radha, V., Kamatkar, S., and Swarup, G.(2000). PTP-S2, a nuclear tyrosine phosphatase, is phosphorylated and excluded from condensed chromosomes during mitosis. J Biosci 25:33-40.

Neel, B. G., and Tonks, N. K.(1997). Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Bio/9:193-204.

Nielson, L. L., Dell, J., Maxwell, E., Armstrong, L., Maneval, D., and Catino, J. J.(1997). Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. Cancer Gene Ther 4:129-138.

Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al.(1989). Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708.

Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., and Tanaka, N.(2000a). Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058.

Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tarnai, K., Tokino, T., Nakamura, Y., and Taya, Y.(2000b). p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Ce//1 02:849-862.

Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., Evans, R., and Nakatani, Y.(1996). The transcriptional coactivators p300 and CBP are histone acetyl transferases. Ce//87: 953-959.

Oliner, J. D., Pietenpol, J. A.; Thiagalingam, S., Gyuris, J., Kinzler, K. W., and Vogelstein, 8.(1993). Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860.

Ona, V. 0., Li, M., Vonsattel, J.P., Andrews, L. J., Khan, S. Q., Chung, W. M., Frey, A. S., Menon, A. S., Li, X. J., Stieg, P. E., Yuan, J., Penney, J. B., Young, A. B., Cha, J. H., and Friedlander, R. M.(1999). Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399:263-267.

Ongkeko, W. M., Wang, X. Q., Siu, W. Y., Lau, A. W., Yamashita, K., Harris, A. L., Cox, L. S., and Poon, R. Y.(1999).MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr Bioi 9:829-832.

Osada, M., Ohba, M., Kawahara, C., lshioka, C., Kanamaru, R., Katoh, 1., lkawa, Y., Nimura, Y., Nakagawara, A., Obinata, M., and lkawa, S.(1998). Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Genet 4, 839-843.

98

Osada, M., Ohba, M., Kawahara, C., lshioka, C., Kanamaru, R., Katoh, 1., lkawa, Y., Nimura, Y., Nakagwara, Y., Obinata, M., and lkawa, S.(1998). Cloning and functional analysis of human p51, which functionally resembles p53. Nat Med 4:839-843.

Owen-Schaub, L.8., W. Zhang, J. C. Cusack, L. S. Angel, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W.-W. Zhang, E. Kruzel and R. Radinsky.(1995). Wild-type human p53 and a temperature sensitive mutant induce fas/AP01 expression. Mol Cell Bio/15: 3032-3040.

Palmero, 1., Pantoja, ·c., and Serrano, M.(1998). p19ARF links the tumor suppressor p53 and Ras. Nature 395, 125-126.

Papavassiliou, A. G., Treier, M., and 8ohmann, D.(1995). Intramolecular signal transduction inc-Jun. EMBO J 14:2014-2019.

Parada, L. F., Land, H., Weinberg, R. A., Wolf, D., and Rotter, V.(1984). Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.Nature 312:649-651.

Pardee, A. 8.(1989). G1 events and regulation of cell proliferation. Science 246:603-614.

Pavletich, N. P., Chambers, K. A., and Pabo, C. o:(1993) The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7: 2556-2564.

Pendergast, A. M.(1996). Nuclear tyrosine kinases: from Abl to WEE1. Curr Opin Cell Bio/8:174-181.

Peng, C. Y., Graves, P.R., Thoma, R. S., Wu, Z., Shaw, A, S., and Piwnica-Worms, H.(1997). Mitotic and G2 checkpoint control: regulation of 14-3-3s protein binding by phosphorylation of Cdc25C on serine-216. Science 277: 1501-1505.

Perry, M. E., Piette, J., Zawadzki, J.A., Harvey, D., and Levine, A. J.(1993). The mdm-2 gene is ·induced in response to UV light in a p53-dependent manner. Proc Nat/ A cad Sci U S A 90:11623-11627.

Peterson, A. J., Kyba, M., Bornemann, D., Morgan, K., Brock, H. W., and Simon, J.(1997). A domain shared by the Polycomb group proteins Scm and ph mediates heterotypic and homotypic interactions. Mol Cell Bio/17: 6683-6692 .

. Pietenpol, J.A., Tokino, T., Thiagalingam, S., EI-Deiry, W.S., Kinzler, K.W., and Vogelstein, 8.(1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc Nat/ Acad Sci USA 91, 1998-2002.

Polyak, K., Xia, Y., Zwier, J.K., Kinzler, K.W., and Vogelstein, B.(1997) A model for p53-induced apoptosis. Nature 389, 300-305.

Pomerantz, J., Schreiber-Agus, N., Liegeois, N.J., Silverman, A., Allan, L., Chin, L., Pates, J., Chen, K., Orlow, 1., Lee, H-W., Cordon-Cardo, C., and DePinho, R.A.(1998). The lnk4a tumor suppressor gene product, p19ARF, interactes with MDM2 and neutralizes MDM2's inhibition of p53. Cell92, 713-723.

Poyet, J. L., Srinivasula, S. M., Tnani, M., Razmara, M., Fernandes-Ainemr,i T., and Alnemri, E. S.(2001 ). Identification of lpaf, a human caspase-1-activating protein related to Apaf-1. J Bioi Chern 276:28309-28313.

Prabhu, N. S., Somasundaram, K., Satyamoorthy, K., Herlyn, M., and EI-Deiry, W.S.(1998): p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells.lnt J Onco/13, 5-9.

99

Prives, C.(1998). Signaling to p53: Breaking the MDM2-p53 Circuit. Cell 95:5-8.

Purdie, C. A., Harrison, D.J., Peter, A., Dobbie, A.L., White, S., Howie, S. E. M., Salter, D.M., Bird, C.C., Wyllie, A.H., Hooper, M.L., and Clarke, A.R.(1994). Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603-609.

Qin, H., Srinivasula, S. M., Wu, G., Fernandes-Ainemri, T., Alnemri, E. S., and Sh,i Y.(1999). Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549-557.

Qu, C. K., Yu, W. M., Azzarelli, B., and Feng, G. S.(1999). Genetic evidence that Shp-2 tyrosine phosphatase is a signal enhancer of the epidermal growth factor receptor in mammals.Proc Nat/ A cad Sci U SA 96:8528-8533.

Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T.(1995). Matlnd and Matlnspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878-84.

Radha, V., Kamatkar, S., and Swarup, G.(1993). Binding of a protein-tyrosine phosphatase to DNA through its carboxy-terminal noncatalytic domain. Biochemistry 32:2194-2201.

Radha, V., Nambirajan, S., and Swarup, G.(1994). Subcellular localization of a protein-tyrosine phosphatase: evidence for association with chromatin. Biochem J 299 ( Pt 1):41-7.

Radha, V., Nambirajan, S., and Swarup, G.(1997). Overexpression of a nuclear protein tyrosine phosphatase increases cell proliferation. FEBS Lett 409:33-36.

Radha, V., and Swarup, G.(1997). Nuclear protein tyrosine phosphatases and control of cell proliferation. Current Science 73: 418-429.

Radha, V., Sudhakar, C., and Swarup, G.(1999). Induction of p53 dependent apoptosis upon overexpression of a nuclear protein tyrosine phosphatase. FEBS Lett 453:308-312.

Rajendrakumar, G. V., Radha, V., and Swarup, G.(1993). Stabilization of a protein-tyrosine phosphatase mRNA upon mitogenic stimulation of T-lymphocytes. Biochim Biophys Acta 1216:205-212.

Rao, A., Luo, C., and Hogan, P. G.(1997). Transcription factors of the NFAT family: regulation and function. Annu Rev lmmunol15:707-747.

Reddy, R. S., and Swarup, G.(1995). Alternative splicing generates four different forms of a non­transmembrane protein tyrosine phosphatase mRNA. DNA Cell Bioi 14:1007-1015.

Roach, P. J.(1991). Multisite and hierarchal protein phosphorylation. J Bioi Chern 266:14139-14142.

Rohan, P. J., Davis, P., Moskaluk, C. A., Kearns, M., Krutzsch, H., Siebenlist, U., and Kelly, K.(1993). PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science 259:1763-1766 .

. Roper, E., Weinberg, W., Watt, F. M., and Land, H.(2001 ). p19ARF-independent induction of p53 and cell cycle arrest by Raf in murine keratinocytes. EMBO Rep 2:145-150.

Ryan, K. M., and Vousden, K. H.(1998). Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol18:3692-3698.

100

Sabbatini, P., and McCormick, F.(1999). Phosphoinositide 3-0H kinase (PI3K) and PKB/Akt delay the onset of p53-mediated, transcriptionally dependent apoptosis. J Bioi Chern 274:24263-24269.

Strano, S., Munarriz, E., Rossi, M., Cristofanelli, B., Shaul, Y., Castagnoli, L., Levine, A. J., Sacchi, A., Cesareni, G., Oren, M., and Blandino, G.(2000). Physical and functional interaction between p53 mutants and different isoforms ofp73. J Bioi Chern 275:29503-29512.

Sadhu, K., Reed, S. I., Richardson, H., and Russell, P.(1990). Human homolog of fission yeast Cdc25 mitotic inducer is predominantly expressed in G2. Proc Nat/ Acad Sci USA 87: 5139-5143.

Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., and Arnheim, N.(1985). Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354.

Sakaguchi, A. Y., Sylvia, V. L., Martinez, L., Smith, E. A., Han, E. S., Lalley, P. A., Shows, T. B., and Choudhury, G. G.(1992). Assignment of tyrosine-specific T-cell phosphatase to conserved syntenic groups on human chromosome 18 and mouse chromosome 18. Genornics 12:151-154.

Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., and Appella, E.(1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev12, 2831-2841.

Salvesen, G. S., and Dixit, V. M.(1997). Caspases: intracellular signaling by proteolysis. Ce//91:443-446.

Sambrook, J., Fritsch, E. F., and Maniatis, T.(1989). Molecular cloning : A laboratory manual. (2nd edition) Cold Spring Harbour Laboratory, CSH, NY.

Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P M.(1993). The HPV-16 E6 and E6-AP Complex Functions As a Ubiquitin-protein Ligase In the Ubiquitination of p53. Cell 75: 495-505.

Schmale, H., and Bamberger, C. (1997). A novel protein with strong homology to the tumor suppressor p53.0ncogene 15:1363-1367.

Schultz, J., Panting, C. P., Hofmann, K., and Bork, P.(1997). SAM as a protein interaction domain involved in developmental regulation. Protein Sci 6:249-253.

Sebastian, B., Kakizuka, A., and Hunter, T.(1993).Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation ofthreonine-14 and tyrosine-15. Proc Nat/ Acad Sci US A 90:3521-3524.

Sefton, B. M., Hunter, T., Beeman, K., and Eckhart, W.(1980). Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Ce//20:807-816.

Selvakumaran, M., Lin, H. K., Miyashita, T., Wang, H. G., Krajewski, S., Reed, J. C., Hoffman, B., and Liebermann, D.(1994). Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways. Oncogene 9:1791-1798.

Senoo, M., Seki, N., Ohira, M., Sugano, S., Watanabe, M., lnuzuka, S., Okamoto, T., Tachibana, M., Tanaka, T., Shinkai, Y., and Kato, H.(1998). A second p53-related protein, p73L, with high homology to p73.Biochern Biophys Res Cornmun 248:603-607.

Sheikh, M. S., Burns, T. F., Huang, Y., Wu, G. S., Amundson, S., Brooks, K. S., Fornace, A. J. Jr., and EI-Deiry, W. S.(1998). p53-dependent and -independent regulation of the death receptor KILLER/DRS gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 58:1593-1598.

101

Shieh, Y., Ikeda, M., Taya, Y., and C. Prives.(1997).DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.

Shaulian, E., Zauberman, A., Ginsberg, D., and M, Oren.(1992). Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding. Mol Cell Biol12: 5581-5592.

Shultz. L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., lhle, J. N., Matthews, R J., Thomas, M. L., and Beier, D. R.(1993). Mutations at the murine motheaten locus are within the hematopoietic cell protein­tyrosine phosphatase (Hcph) gene. Cell73:1445-1454.

Slack, R. S., Belliveau, D. J., Rosenberg, M., Atwal, J., Lochmuller, H., Aloyz, R., Haghighi, A., Lach, B., Seth, P., Cooper, E., and Miller, F. D.(1996). Adenovirus-mediated gene transfer of the tumor suppressor, p53, induces apoptosis in postmitotic neurons. J Cell Biol135:1085-1096.

Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S-Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.H., and Lowe, S.W.(1998) E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev 12, 2434-2442.

Steegenga, W. T., Shvarts, A.., Riteco, N., Bos, J. L., and Jochemsen, S.G.(1999), Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B and E4orf6 proteins. Mol Cell Biol9: 3885-3894.

Stenger, J. E., Tegtmeyer, P., Mayr, G. A., Reed, M., Wang, Y., Wang, P., Hough, P. V., and Mastrangelo, I. A.(1994). p53 oligomerization and DNA looping are linked with transcriptional activation. EMBO J 13: 6011-6020.

Stone, S., Jiang, P., Dayanath, P., Tavtgian, S.V., Katcher, H., Parry, D., Peters, G., and Kamb, A.1995) Complex structure and regulation of the p16 (MTS 1) locus. Cancer Res 55, 2988-2994.

Sugrue, M. M., Shin, D. Y., Lee, S. W., and Aaronson, S. A.(1997). Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Nat/ Acad Sci U SA 94:9648-9653.

Swarup, G., Kamatkar, S., Radha, V., and Rema, V.(1991). Molecular cloning and expression of a protein-tyrosine phosphatase showing homology with transcription factors Fos and Jun. FEBS Lett 280:65-69.

Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T.(1994). p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711.

Tak, P. P., Zvaifler, N.J., Green, D. R., and Firestein, G. S.(2000). Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. lmmunol Today 21:78-82.

Takada, N., Ozaki, T., lchimiya, S., Todo, S., and Nakagawara, A.(1999). Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occuring mutants found in human neuroblastomas. Cancer Res 59:2810-2814.

Takagi, T., Taylor, G. S., Kusakabe, T., Charbonneau, H., and Buratowski, S.(1998). A protein tyrosine phosphatase-like protein from baculovirus has RNA 5'-triphosphatase and diphosphatase activities. Proc Nat/ Acad Sci US A 95(17):9808-9812

Tan, M., Wang, Y., Guan, K., and Sun, Y.(2000). PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway. Proc Natl Acad Sci US A 97:109-114.

102

..

Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y.{2000). A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404:42-49.

Tao, W., and Levine, A. J.(1999). P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of MDM2.Proc Nat/ Acad Sci U SA 96:6937-6941.

Tatsuta, T., Shiraishi, A., and Mountz, J. D.(2000). The prodomain of caspase-1 enhances Fas­mediated apoptosis through facilitation of caspase-8 activation.J Bioi Chern 275:14248-14254.

Taylor, G. S., Maehama, T., and Dixon. J. E.(2000). Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate Proc Nat/ Acad Sci US A 97: 8910-8915.

Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J. L., Mattmann, C., and Tschopp, J.(1998). Identification of CARDIAK, a RIP-like kinase that associates with caspase-1.Curr Bioi 8:885-888.

Thompson, C. B.(1995). Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.

Thornberry, N. A., and Lazebnik, Y.(1999). Caspases: enemies within. Science 281:1312-1316.

Thut, C., J. Chen, L., Klemm, R., and Tijian, T.{1995). p53 transacriptional activation mediated by co activators TAF1140 and TAF 1160. Science 267, 100-104.

Tiganis, T., Flint, A. J., Adam, S. A., and Tonks, N. K.(1997). Association of the T-cell protein tyrosine phosphatase with nuclear import factor p97. J Bioi Chern 272:21548-21557.

Tiganis, T., Bennett, A. M., Ravichandran, K. S., and Tonks, N. K.(1998). Epidermal growth factor receptor and the adaptor protein p52Shc are specific substrates of T-cell protein tyrosine phosphatase. Mol Cell Bio/18:1622-1634.

Tiganis, T., Kemp, B. E., and Tonks, N. K.(1999). The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling. J Bioi Chern 274:27768-27775.

Tillmann, U., Wagner, J., Boerboom, D., Westphal, H., and Tremblay, M.L. (1994).Nuclear localization and cell cycle regulation of a murine protein tyrosine phosphatase. Mol Cell Bio/14:3030-3040.

Tlsty, T.D.(1997). Genomic instability and its role in neoplasia. Curr Top Microbio/lmrnuno/221:37-46 .

. Ueda, Y., Hijikata, M., Takagi, S., Chiba, T., and Shimotohno, K. (1999). New p73 variants with altered C-terminal Structures have varied transcriptional activities. Oncogene 18: 4993-4998.

Ueki, T., Takeuchi, T., Nishimatsu, H., Kajiwara, T., Moriyama, N., Narita, Y., Kawabe, K., Ueki, K., and Kitamura, T.(2001). Silencing of the caspase-1 gene occurs in murine and human renal cancer cells and causes solid tumor growth in vivo. tnt J cancer 91: 673-679.

Ushiro, H., and Cohen, S.(1980). Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes. J Bioi Chern 255:8363-8365.

Van Vactor, D., O'Reilly, A.M., and Neel, B. G.(1998). Genetic analysis of protein tyrosine phosphatases. Curr Opin Genet Oev 8:112-126.

103

Villa-Moruzzi, E., Puntoni, F., Bardelli, A., Vigna, E., De Rosa, S., and Comoglio, P. M. Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met. Biochem J 36 ( Pt 1):235-239.

Vogelstein,B., and Kinzler, K. W.(1992). p53 function and dysfunction. Ce//70:523-526.

Vogelstein, B., Lane, D., and Levine, A. J.(2000). Surfing the p53 network. Nature. 408:307-310.

Wahl, G. M., Linke, S. P., Paulson, T. G., and Huang, L. C.(1997). Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv. 29:183-219.

Waldman, T., Kinzler, K., and Vogelstein, B.(1995). p21WAF1 is necessary for the p53-mediated G 1 arrest in human cancer cells. Cancer Res 55, 5187-5190.

Walker, N. P., Talanian, R. V., Brady, K. D., Dang, L. C., Bump, N J., Ferenz, C. R., Franklin, S., Ghayur, T., Hackett, M. C., and Hammill, L. D.(1994).Crystal Structure of the Cysteine Protease interleukin-1 ~Converting Enzyme: a (p20/p1.0)2 Homodimer. Cell 78: 343-352.

Wang, X. W., Vermeulen, W., Coursen, J.D., Gibson, M., Lupoid, S.e., Forrester, K., Xu, G., Elmore, L., Yeh, H., Hoeijmakers, J.H., and Harris,C.C~(1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. Genes Dev 10, 1219-1232.

Wang, X. W., Forrester, K., Yeh, H., Feitelson, M.A., Gu, J-R., and Harris, C.C.(1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Nat/ Acad Sci USA 91, 2230-2234.

Wang, Y., Reed, M., Wang, P., Stenger, J. E., Mayr, G., Anderson, M. E., Schwedes, M. E., and Tegtmeyer, P.(1993). p53 domains:identification and characterization of two autonomous DNA­binding regions. Genes Dev 7, 2575-2586.

Wang, Z., and Rossman, T. G.(1994). Isolation of DNA fragments from agarose gel by centrifugation. Nucleic Acids Res 22:2862-2863.

Waterman, M. J. F., Stavridi,E. S., Waterman, J. L. F., and Halazonetis, T.D.(1998). ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 19, 175-178.

Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., and Bar-Sagi, D.(1999). Nucleolar Arf sequesters MDM2 and activates p53. Nat Cell Bio/1 :20-26.

Wee, C., Muise, E. S., Coquelet, 0., Ennis, M., Wagner, J., Lemieux, N., Branton, P. E., Nepveu, A., and Tremblay, M. L.(1999). Promoter analysis of the murine T-cell protein tyrosine phosphatase gene. Gene 237:351-360.

Weng, L. P., Yuan, J., and Yu, 0.(1998). Overexpression of the transmembrane tyrosine phosphatase LAR activates the caspase pathway and induces apoptosis. Curr Bio/8:247-256.

Whitmarsh, A. J., and Davis, R.J.(2000). Regulation of transcription factor function by phosphorylation. Cell Mol Life Sci 57:1172-1183.

Wilson, K. P., Black, J. A., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko. M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., et al. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370:270-275.

Wyllie, A.H.(1997). Apoptosis: an overview. BrMed Bull 53:451-465.

104

Wynford-Thomas D.(1996). p53: guardian of cellular senescence. J Patho/180:118-1121.

Wynford-Thomas D.(1997). Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology. Eur J Cancer 33:716-726.

Yang, A., and McKeon, F.(2000). P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Bioi. 1:199-207.

Yang, A., Kaghad, M., Wang, Y., Gillett, E., Fleming, M. D., Dotsch, V., Andrews, N.C., Caput, D., and McKeon, F.(1998). p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316.

Yang, A., Sch~eitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T.,. Tabin, C., Sharpe, A., Caput, D., Crum, C., and McKeon, F.(1999). p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:_7 14-718.

Yang, A., Walker, N., Bronson, R., Kaghad, M., Oosterwegel, M., Bonnin, J., Vagner, C., Bonnet, H., Dikkes, P., Sharpe, A., Mckeon, F., and Caput, D.(2000). p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103.

Yeargin, J., and Haas, M.(1995). Elevated levels of wild-type p53 induced by radiolabeling of cells leads to apoptosis or sustained growth arrest. Curr Bioi 5: 423-431.

Yin, C., Knudson, C. M., Korsmeyer, S. J., and Van Dyke, T.(1997). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385:637-640.

Yin, Y., Tainsky, M.A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M.(1992). Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70: 937-948.

You-Ten, K. E., Muise, E.S., ltie, A., Michaliszyn, E., Wagner, J., Jothy, S., Lapp, W. S., and Tremblay, M. L.(1997). Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice. J Exp Med 186:683-693.

Yu, J., Zhang, L., Hwang, P.M., Rago, C., Kinzler, K. W., and Vogelstein, B.(1999). Identification and classification of p53-regulated genes. Proc Nat/ Acad Sci USA. 96:14517-14522.

Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., and Vogelstein, B.(2001). PUMA induces the rapid apoptosis of colo rectal cancer cells. Mol Cell 7:673-682.

Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R.(1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641-652.

Yuan, Z. M., Huang, Y., lshiko, T., Kharbanda, S., Weichselbaum, R., and Kufe, 0.(1997). Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc Nat/ Acad Sci US A 94:1437-1440.

Zaika, A., Irwin, M., Sansome, C., and Moll, U.M.(2001). Oncogenes induce and activate endogenous p73 protein. J Bioi Chem 276:11310-11316.

Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, 1., Castedo, M., and Kraemer, G.(1996). Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533-1544.

105

Zeng, X., Chen, l., Jost, C. A., Maya, R., Keller, D., Wang, X., Kaelin, W. G. Jr., Oren, M., Chen, J., ·and Lu, H.(1999). MDM2 suppresses p73 function without promoting p73 degradation. Mol Cell Bioi 19:3257-3266.

Zhan, Q., Carrier, F., and Fornace, A. J. Jr.(1993). Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Mol Cell Bioi 13, 4242-4250.

Zhang, Z. Y.(1997). Structure, mechanism, and specificity of protein-tyrosine phosphatases. Curr Top Cell Regul 35:21-68.

Zhang, Y., Xiong, Y., and Yarbrough, W.G.(1998). ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.

Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., and Levine, A. J.(2000). Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14:981-993.

Zheng, X., and Chen, X.(2001). Aquaporin 3, a glycerol and water transporter, is regulated by p73 of the p53 family. FEBS Lett 489:4-7.

Zhu, J., Jiang, J., Zhou, W., and Chen, X.(1998). The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res 58:5061-5065.

Zindy, F., Eischen, D. H., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr. C.J., and Roussel, M.F.(1998) MYC-induced immortalization and apoptosis targets the ARF-p53 pathway. Genes Dev 12, 2424-2433.

Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X.(1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90:405-413.

Zou, H., Li, Y., Liu, X., and Wang, X.(1999). An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Bioi Chern 27 4:11549-11556.

Zuo, Z., Dean, N. M., and Honkanen, R. E.(1998). Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21 (WAF1/Cip1) and mediate growth arrest. J Bioi Chern 273:12250-12258.

106